by Team Small News | Jul 4, 2025 | Cipla, Glenmark, Lupin, Mankind, Pharma
Lupin, a leading pharmaceutical company, has created a new subsidiary called LupinLife Consumer Healthcare Ltd to house its consumer healthcare business. This move is in line with a growing trend among pharmaceutical companies, both in India and globally, to separate... by Team Small News | Jun 27, 2025 | Glenmark, Pharma
Alexey Cherchago, a leading expert in the pharmaceutical industry, recently discussed Glenmark’s focus on innovation and technology in the evolving pharmaceutical market. Glenmark, a global pharmaceutical company, has been at the forefront of innovation,... by Team Small News | Jun 19, 2025 | Glenmark, Pharma
The U.S. Food and Drug Administration (FDA) recently conducted a Good Manufacturing Practice (GMP) inspection of Glenmark Pharmaceuticals’ manufacturing facility in Monroe, North Carolina. The inspection, which took place from June 9-17, resulted in the FDA... by Team Small News | Jun 18, 2025 | Glenmark, Pharma
Glenn Saldanha, Chairman and Managing Director of Glenmark Pharmaceuticals Ltd, reflects on the company’s over two-decade journey, highlighting the challenges of transitioning from a generic-focused business to a more innovative space. Saldanha notes that this... by Team Small News | Jun 11, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals, a renowned drug company, has announced its plan to launch a cancer treatment drug called zanubrutinib, also known as Brukinsa, in India. The drug has been approved by the Drugs Controller General of India (DCGI) and will be used to treat five... by Team Small News | Jun 6, 2025 | Glenmark, Pharma
Glenmark, an Indian pharmaceutical company, recently reported its earnings for the 2025 financial year. While the company’s overall performance was affected by a weak second half in its India business, it is planning to revive growth in both its core markets:...